1. Value-Based Pricing

   • Dyfrig A. Hughes

   Editorial 23 September 2012 Pages: 731 - 735

2. Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies

   • Petros Pechlivanoglou
   • Robin De Vries
   • Maarten J. Postma

   Leading Article 23 September 2012 Pages: 737 - 751

   

3. Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure

   • Alexander Goehler
   • Benjamin P. Geisler
   • Uwe Siebert

   Review Article 23 September 2012 Pages: 753 - 769

   

4. To Fund or Not to Fund

   • Tania Stafinski
   • Devidas Menon
   • Donald J. Philippon

   Original Research Article 23 September 2012 Pages: 771 - 780

   

5. Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand

   • Naiyana Praditsitthikorn
   • Yot Teerawattananon
   • Viroj Tangcharoensathien

   Original Research Article 23 September 2012 Pages: 781 - 806

   

6. Cinacalcet

   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 23 September 2012 Pages: 807 - 821